Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

DS 4574

Known as: DS-4574 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
We evaluated the inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on rat gastric… Expand
  • figure 1
  • table 1
  • figure 2
2005
2005
The antisecretory effect of DS-4574, a mast cell stabilizer with peptidoleukotriene antagonism, on the hypersecretion of gastric… Expand
  • figure 1
  • figure 2
  • figure 3
1995
1995
We evaluated the protective effect of DS-4574 (6-(2-cyclohexylethyl)-[1,3,4]thiadiazolo[3,2-a]-1,2,3- triazolo[4,5-d]pyrimidin-9… Expand
1994
1994
We examined the inhibitory effect of DS-4574 (6-(2-cyclohexylethyl)[1,3,4]thiadiazolo[3,2-alpha]-1,2,3- triazolo[4,5-d] pyrimidin… Expand
1993
1993
The anti-allergic and anti-inflammatory activities of DS-4574, which possesses leukotriene antagonism and inhibits the release of… Expand
1993
1993
We studied the leukotriene (LT) antagonistic activity of DS-4574 in vivo and the inhibitory effect of this compound on antigen… Expand
1993
1993
We compared the protective effect of DS-4574, a peptidoleukotriene receptor antagonist with mast cell stabilizing action, on rat… Expand
1992
1992
The antiallergic activity of DS-4574 was evaluated in several commonly used rat models for allergic diseases. In passive… Expand
1992
1992
DS-4574 is a peptidoleukotriene antagonist with mast cell stabilizing activity. In the present study, we studied the effects of… Expand
1991
1991
We investigated the effect of a new antiallergic agent, DS-4574, on the guinea-pig smooth muscle contractions induced by… Expand